The Diagnosis and Management of Asthma During Pregnancy

Luskin, Allan T.; Lipkowitz, Myron A.

doi:10.1016/s0889-8561(05)70181-8

Cited by 3 publications

(2 citation statements)

References 46 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Luskin and Lipkowitz state that when giving any treatment during pregnancy, one must obtain informed consent. This should include an explanation of the consequences of failing to prescribe therapy that may alleviate the effects of potentially life-threatening asthma to the mother, fetus or both [45]. Frequent communication between the patient and the physician is key for optimal management of asthma during pregnancy [46].…”

Section: Quality Of Care and Pregnancy Outcomes In Patients With Asthmamentioning

confidence: 99%

Quality of care of asthma during pregnancy

Streck¹,

Blaiss²

2006

Expert Review of Pharmacoeconomics & Outcomes Research

View full text Add to dashboard Cite

The goal of asthma management during pregnancy is to keep the mother symptom free and to prevent complications in the fetus. Asthma is a common chronic condition in pregnancy that, if inadequately treated, has the potential to cause adverse effects for both mother and fetus. Aggressive treatment during pregnancy can decrease costs associated with asthma now and additional costs later if the fetus has a poor outcome due to maternal asthma. A stepwise approach to the management of asthma during pregnancy has been developed and is not unlike the management of the nonpregnant patient. Although there are no double-blind, placebo-controlled studies on asthma medications in pregnant women, large cohort studies have shown the efficacy of aggressive management. With adequate control of asthma from the preconception time through delivery, studies have shown similar outcomes in asthmatic patients compared with nonasthmatics, thus obtaining the goal of a symptom-free mother and a healthy baby.

show abstract

Section: Quality Of Care and Pregnancy Outcomes In Patients With Asthmamentioning

confidence: 99%

Quality of care of asthma during pregnancy

Streck¹,

Blaiss²

2006

Expert Review of Pharmacoeconomics & Outcomes Research

View full text Add to dashboard Cite

show abstract

“…Гестоз относится к одной из основных проблем современного акушерства, оставаясь главной причиной материнской и перинатальной смертности [2]. Особенно часто гестоз развивается на фоне экстрагенитальных заболеваний, в том числе у беременных с бронхиальной астмой (БА) [1,2,9,12,13]. В настоящее время главным звеном в механизмах развития гестоза считают генерализованное нарушение функции эндотелиальных клеток сосудов, при этом осложнению во многом свойственны черты системного воспаления [5,6,7,11].…”

unclassified

The mechanisms of activization of endothelium at the pregnant patients with bronchial asthma and gestosis

Махмутходжаев¹,

Ogorodova²,

Radionchenko³

et al. 2002

Bûll. sib. med.

View full text Add to dashboard Cite

At pregnant women with gestosis the increasing of concentration in blood serum of soluble molecules of adherence sVCAM-1 and sICAM-1 is discovered. The same changes are revealed at pregnant with bronchial asthma, the period of gestosis being 18 weeks. With it there is a positive correlation between the substance of soluble molecules of adherence and the concentration of cytokines of atopic inflammation in blood serum.

show abstract

Gender-Specific Asthma Treatment

Choi

2011

Allergy Asthma Immunol Res

View full text Add to dashboard Cite

Because genetic characteristics vary among subjects, the therapeutic effects of a certain drug differ among patients with the same disease. For this reason, special interest has focused on tailored treatments. Although it is well known that sex is genetically determined, little attention has been paid to sex differences in the clinical features and treatment of asthma. Females are more likely to suffer allergic asthma, to have difficulty controlling asthma symptoms, and to show adverse effects to drugs. As asthma symptoms show cyclic changes depending on female hormone levels in many women of child-bearing age, the use of contraceptives may specifically help to treat female patients with asthma such as those with perimenstrual asthma and severe asthma. Generally, testosterone seems to suppress asthma, and dehydroepiandrosterone (DHEA), a less virilizing androgen, may be effective for treating asthma. Evidence exists for a therapeutic and steroid-sparing effect of DHEA. However, further studies on the optimal dose and route of DHEA for each sex are needed. Monitoring of the serum DHEA-S level is necessary for patients with asthma on inhaled steroid treatment, and at minimum, replacement therapy for patients with a low level of DHEA may be helpful for treating their asthma.

show abstract

The Diagnosis and Management of Asthma During Pregnancy

Cited by 3 publications

References 46 publications

Quality of care of asthma during pregnancy

Quality of care of asthma during pregnancy

The mechanisms of activization of endothelium at the pregnant patients with bronchial asthma and gestosis

Gender-Specific Asthma Treatment

Contact Info

Product

Resources

About